Floatz logo

Carboplatin

Leptomeningeal Metastases

Guangzhou Medical UniversitySmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Leptomeningeal Metastases cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Fudan University
Phase 4BBB
PACLITAXEL TREVATIDE
Angiochem Inc
Phase 3B
Hycamtin
National Cancer Institute (NCI)
Phase 2B
Tesevatinib
Kadmon Corporation, LLC
Phase 2CCC
Folic Acid
The First Hospital of Jilin University
Phase 1CC

View all 10 →

Same molecule, other indications

Carboplatin is also rated in:

lung large cell carcinomaDormant
A
Indicative ·
80 / 100
View asset →
non-small cell squamous lung carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →